fontolizumab planned trade name huzaf humanized monoclonal immunosuppressive drug treatment autoimmune diseases like crohns phase ii clinical trial investigating use rheumatoid arthritis terminated first phase meet immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikifontolizumab